Apoptosis

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

In space, worms help study microgravity effects

Published July 9, 2009, 1:29 pm, MSNBC

A transparent roundworm could reveal the biological effects of microgravity and space radiation, and perhaps provide clues on how to protect future human astronauts headed for the moon, Mars and beyond.

Discover News | Full Story


Worms in Space to Study Microgravity

Published July 9, 2009, 7:29 am, SPACE.com

A worm experiment in space could yield clues on protecting future astronauts on long missions.

Discover News | Full Story


Molecules With A Higher Selective Ability To Kill Cancer Cells

Published July 9, 2009, 7:15 am, redOrbit

Researchers of the Department of Pharmaceutical Chemistry of the University of Granada (UGR), led by Joaquín Campos Rosa, have obtained a new type of molecules which have proven -in in vitro cultivations- a high level of efficiency against cancer cells, as well as very low toxicity against the body's normal cells.

Discover News | Full Story


Molecules Discovered With A Higher Selective Ability To Exterminate Cancer Cells

Published July 9, 2009, 5:20 am, Science Daily

Researchers have obtained a new type of molecules which have proven -in in vitro cultivations- a high level of efficiency against cancer cells, as well as very low toxicity against the body’s normal cells.

Discover News | Full Story


Data Published in the New England Journal of Medicine Support Use of Raxibacumab (ABthrax (TM)) for the Treatment of ...

Published July 9, 2009, 4:42 am, Newswise

Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication by The New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug raxibacumab (ABthrax (TM)), as well as the results of human safety studies, which supported the use of raxibacumab in the event of ...

Discover News | Full Story


Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of ...

Published July 9, 2009, 4:00 am, PR Newswire via Yahoo! Finance

Human Genome Sciences, Inc. today announced publication by The New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug raxibacumab (ABthrax), as well as the results of human safety studies, which supported the use of raxibacumab in the event of life-threatening inhalation anthrax ...

Discover News | Full Story


Cellumen Launches Rat Cardiomyocyte Early Safety Assessment Panel, Signs Contract with International Biotech Company

Published July 8, 2009, 1:18 pm, Business Wire via Yahoo! Finance

PITTSBURGH----Cellumen, Inc., a discovery and early safety assessment company, today announced that it has added a Rat Cardiomyocyte Panel to its CellCiphr® Early Safety Assessment services.

Discover News | Full Story


Researchers Discover That Phenoxodiol Kills Rapidly Proliferating T-Cells

Published July 8, 2009, 7:15 am, Medical News Today

Researchers at the Malaghan Institute of Medical Research in Wellington, New Zealand have found that abnormally proliferating human T-cells, rapidly dividing cancer cells such as primary myeloid and lymphoid leukemic blast cells undergo programmed cell death when exposed briefly to the investigational anti-tumor drug phenoxodiol.

Discover News | Full Story


IP Update

Published July 7, 2009, 12:18 pm, GenomeWeb News

"This invention features permeability-enhancer molecules and methods to increase membrane permeability of various molecules, such as nucleic acids, polynucleotides, oligonucleotides, enzymatic nucleic acid molecules, antisense nucleic acid molecules, 2-5A antisense chimeras, triplex forming oligonucleotides, decoy RNAS, dsRNAs, siRNAs, aptamers, or antisense nucleic acids containing nucleic acid ...

Discover News | Full Story


Research and Markets: Aurora Kinase Inhibitors - A Competitor Evaluation In The Field Of Synthetic Molecules Targeting ...

Published July 7, 2009, 8:00 am, Business Wire via Yahoo! Finance

DUBLIN----Research and Markets has announced the addition of the "Competitor Analysis: Aurora Kinase Inhibitors" report to their offering.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a